Revising the available literature, several studies reported that the expression of some inhibitors of Bcl-2 cell death was reduced in thyroid cancer patients, while inducers of Bax cell death increased in those patients [21,22]. This evidence concerns the gene BAX and thyroid gland carcinoma.